These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Advances in diagnosis and treatment of AL amyloidosis]. Zelichowski G, Lubas A, Wańkowicz Z. Pol Merkur Lekarski; 2008 Apr; 24(142):340-5. PubMed ID: 18634370 [Abstract] [Full Text] [Related]
3. [Polyneuropathy is an early finding in primary systemic amyloidosis]. Romi F, Vedeler C, Tysnes OB, Mørk S, Aarli JA. Tidsskr Nor Laegeforen; 2000 Apr 30; 120(11):1291-3. PubMed ID: 10868089 [Abstract] [Full Text] [Related]
4. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know]. Arbustini E, Gavazzi A, Merlini G. Ital Heart J Suppl; 2002 Jun 30; 3(6):590-7. PubMed ID: 12116807 [Abstract] [Full Text] [Related]
5. Cardiac transplantation using extended-donor criteria organs for systemic amyloidosis complicated by heart failure. Maurer MS, Raina A, Hesdorffer C, Bijou R, Colombo P, Deng M, Drusin R, Haythe J, Horn E, Lee SH, Marboe C, Naka Y, Schulman L, Scully B, Shapiro P, Prager K, Radhakrishnan J, Restaino S, Mancini D. Transplantation; 2007 Mar 15; 83(5):539-45. PubMed ID: 17353770 [Abstract] [Full Text] [Related]
6. AL amyloidosis with renal involvement. Rysavá R. Kidney Blood Press Res; 2007 Mar 15; 30(6):359-64. PubMed ID: 17851224 [Abstract] [Full Text] [Related]
7. Primary amyloidosis of the kidney. Shafique S, Wetmore J, Almehmi A. W V Med J; 2010 Mar 15; 106(1):22-4. PubMed ID: 20088306 [Abstract] [Full Text] [Related]
8. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome. Bergesio F, Ciciani AM, Manganaro M, Palladini G, Santostefano M, Brugnano R, Di Palma AM, Gallo M, Rosati A, Tosi PL, Salvadori M, Immunopathology Group of the Italian Society of Nephrology. Nephrol Dial Transplant; 2008 Mar 15; 23(3):941-51. PubMed ID: 17951308 [Abstract] [Full Text] [Related]
9. Successful heart transplantation following melphalan plus dexamethasone therapy in systemic AL amyloidosis. Mignot A, Bridoux F, Thierry A, Varnous S, Pujo M, Delcourt A, Gombert JM, Goujon JM, Favreau F, Touchard G, Herpin D, Jaccard A. Haematologica; 2008 Mar 15; 93(3):e32-5. PubMed ID: 18310532 [Abstract] [Full Text] [Related]
10. Clinical aspects of multiple myeloma and related disorders including amyloidosis. Kyle RA. Pathol Biol (Paris); 1999 Feb 15; 47(2):148-57. PubMed ID: 10192881 [Abstract] [Full Text] [Related]
11. Immunoglobulin light chain amyloidosis: 2011 update on diagnosis, risk-stratification, and management. Gertz MA. Am J Hematol; 2011 Feb 15; 86(2):180-6. PubMed ID: 21264900 [Abstract] [Full Text] [Related]
15. AL amyloidosis manifesting as systemic lymphadenopathy. Matsuda M, Gono T, Shimojima Y, Yoshida T, Katoh N, Hoshii Y, Yamada T, Ikeda S. Amyloid; 2008 Jun 15; 15(2):117-24. PubMed ID: 18484338 [Abstract] [Full Text] [Related]
16. [Primary systemic amyloidosis presenting as polymyalgia rheumatica and giant cell arteritis]. Pantoja Zarza L, Paniagua De La Riva J, Megido Lahera M, Ortiz De Saracho J. An Med Interna; 2001 Apr 15; 18(4):205-7. PubMed ID: 11496541 [Abstract] [Full Text] [Related]
18. Primary AL (kappa-light chain) amyloidosis manifesting as peripheral neuropathy in a young male without increase in serum and urine immunoglobulin load: a diagnostic challenge. Sarkar C, Chand Sharma M, Nayak A, Mercy Ralte A, Gupta V, Singh S, Behari M. Clin Neuropathol; 2005 Apr 15; 24(3):118-25. PubMed ID: 15943163 [Abstract] [Full Text] [Related]